Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Original Research

Parental views on active commuting and choice of mode of school transport

Claudia Chaufan, Jarmin Yeh, Leslie Ross, Patrick Fox.

Cited by (1)

Background: Over the last three decades, there have been dramatic changes in the independence and mobility of school-age children, compared to prior generations. A few decades ago, a majority of children routinely roamed their neighborhoods and walked or biked to school and other destinations. Today, parents chauffeur their children to nearly all their activities, often under the pressure of multiple family obligations or out of fear for their safety. In order to encourage active commuting among school-age children, it is critical to understand how parents’ views and concerns influence commuting practices.

Methods: We examined parents’ views on active commuting and their association with children’s actual commuting practices. We analyzed parents’ survey responses (N=63,078) collected in October 2010 from the Safe Routes to School (SRTS) program in California.

Results: Children whose parents viewed active commuting as fun, healthy, or encouraged by their child’s school were around three times more likely to actively commute than those whose parents did not hold these views. Children whose parents were open to allowing their child to actively commute if their safety and convenience concerns were addressed were as much two times more likely to actively commute than those whose parents were not open to this change.

Conclusions: Parental views on active modes of school transport play a key role in children’s commuting practices. A more thorough investigation of their perspectives could inform community health and transportation policies action and increase parental support for SRTS efforts, thus help implement successful and sustainable programs.

Key words: Safe Routes to School, active mobility, parental views, childhood obesity prevention

Similar Articles

SODA MAPS: A Framework for Understanding Caffeinated Sugary Drink Consumption Among Children.
Halberg SE, Visek AJ, Blake EF, Essel KD, Sacheck J, Sylvetsky AC
Frontiers in nutrition. 2021; 8(): 640531

Antioxidant films and coatings based on starch and phenolics from Spondias purpurea L.
Rodrigues FAM, Dos Santos SBF, de Almeida Lopes MM, Guimarães DJS, de Oliveira Silva E, de Sá Moreira de Souza Filho M, Mattos ALA, da Silva LMR, de Azeredo HMC, Ricardo NMPS
International journal of biological macromolecules. 2021; ():

Efficacy and safety of glucagon-like peptide-1/glucagon receptor co-agonist JNJ-64565111 in individuals with obesity without type 2 diabetes mellitus: A randomized dose-ranging study.
Alba M, Yee J, Frustaci ME, Samtani MN, Fleck P
Clinical obesity. 2021; 11(2): e12432

Efficacy and safety of glucagon-like peptide-1/glucagon receptor co-agonist JNJ-64565111 in individuals with type 2 diabetes mellitus and obesity: A randomized dose-ranging study.
Di Prospero NA, Yee J, Frustaci ME, Samtani MN, Alba M, Fleck P
Clinical obesity. 2021; 11(2): e12433

Prevalence of depression, anxiety and associated factors among school going adolescents in Bangladesh: Findings from a cross-sectional study.
Islam MS, Rahman ME, Moonajilin MS, van Os J
PloS one. 2021; 16(4): e0247898

Rapid screening and separation of active compounds against α-amylase from Toona sinensis by ligand fishing and high-speed counter-current chromatography.
Meng J, Li Q, Cao Z, Gu D, Wang Y, Zhang Y, Wang Y, Yang Y, He F
International journal of biological macromolecules. 2021; 174(): 270-277

Hypothalamic Actions of SIRT1 and SIRT6 on Energy Balance.
Quiñones M, Martínez-Grobas E, Fernø J, Pérez-Lois R, Seoane LM, Al Massadi O
International journal of molecular sciences. 2021; 22(3):

Severe toxicity of capecitabine in a patient with DPD deficiency after a safe FEC-100 experience: why we should test DPD deficiency in all patients before high-dose fluoropyrimidines.
Maillard M, Eche-Gass A, Ung M, Brice A, Marsili S, Montastruc M, Puisset F, Thomas F
Cancer chemotherapy and pharmacology. 2021; ():

Full-text options

American Journal of Diagnostic Imaging


Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.